Antibiotics Market Size, Industry, Trend, Growth Analysis By 2028

The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.

Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection. Some of the common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat), and among others.

Market Insights

Increasing Development of Generic Drugs

A generic medicine is a copy of a branded drug that is no longer under patent. Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, according to a study published on the NCBI in 2018, the average brand name prescription price was almost 4-times the average generic price. Additionally, the companies are also focusing on the development of generic versions with an aim to offer antibiotics at minimal costs. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Further, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the antibiotics market during the forecast period. For instance, in February 2019, the US Food and Drug Administration (US FDA) announced approval for commercialization of generic medicines manufactured by Indian drug companies in the US.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Antibiotics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Test Type Insights

Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2020; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.

Action-Mechanism Insights

Based on action mechanism, the antibiotics market has been segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2020, whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.

Product launches and approval strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide and meet the growing demand.

The market players operating in the antibiotics market adopt the strategy of expansion to enlarge customer base across the world, which also permits the players to maintain their brand name globally. For instance, in July 2019, the company such as Pfizer has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.

Antibiotics Market Regional Insights

The regional trends and factors influencing the Antibiotics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Antibiotics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Antibiotics Market Report Scope

Antibiotics Market Players Density: Understanding Its Impact on Business Dynamics

The Antibiotics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Antibiotics Market are:

1. Pfizer, Inc
2. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
3. Abbott,
4. GlaxoSmithKline Plc,
5. Sanofi,

Disclaimer: The companies listed above are not ranked in any particular order.

Global Antibiotics Market – By Drug Class

• Cephalosporin
• Penicillin
• Fluoroquinolones
• Macrolides
• Carbapenem
• Aminoglycosides
• Sulfonamides
• Others

Global Antibiotics Market – By Action Mechanism

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Global Antibiotics  – By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

• South America

  • Brazil
  • Argentina
  • Rest of South America

Company Profiles

• Pfizer, Inc
• Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
• Abbott,
•  GlaxoSmithKline Plc,
• Sanofi,
•  Novartis AG,
•  Bayer AG,
• Bristol Myers Squibb Company,
• Eli Lilly and Company,
• Astellas Pharma